BioSpace News Archive

Bird Rock Bio, Inc., a clinical stage biopharmaceutical company, announced today that the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a phase 2 clinical study of nimacimab, also known as RYI-018, in patients with one of the following renal dis

Humanetics Corporation (Humanetics) today announced that an abstract reporting the results of a clinical trial of BIO 300 in non-small cell lung cancer patients undergoing radiochemotherapy has been selected for oral presentation at the annual meeting of the American Society for Radiation Oncology taking place virtually from October 25-28, 2020.

AXONIS Therapeutics , Inc., an emerging biotechnology company advancing breakthrough research to treat spinal cord injury and paralysis, today announced the close of the first tranche of a $4 million Seed Preferred financing. The financing was led by Kerry Murphy, an investor, philanthropist and AXONIS Board member. The funds will enable AX

Vaxxas Announces That Merck Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease.

Catalytic Data Science, a leading provider of life sciences R&D workflow solutions, announced that it has joined the XPRIZE Pandemic Alliance to help develop new diagnostic and therapeutic approaches that mitigate COVID-19.

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of medical equipment industry executive Nick Hoffman as Director, Business Development, effective immediately.

Cellulotech, a company focused on research and development around cellulose, today announced that paper treated with the team’s revolutionary chromatogeny technology has passed the blood/fluid resistance (ASTM F1862) test in an independent United States laboratory.

In honor of Oncology Nursing Month, the Oncology Nursing Society announced the two awardees selected in the Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology.

Precision UpNEXT is a virtual waiting room for healthcare providers to safely & efficiently treat patients due to the pandemic